HomeMarketsEarningsNevro (NVRO) CEO On Chronic Pain Treatments

Nevro (NVRO) CEO On Chronic Pain Treatments

Nevro (NVRO) is a medical device company that delivers solutions for the treatment of chronic pain. CEO Kevin Thornal joins Oliver Renick to give an overview of the company. NVRO is up over 16% this month. Thornal discusses the latest developments in chronic pain treatments. He then goes over NVRO’s earnings. Its adjusted EPS came in at -$0.65 versus an estimated -$0.77 and revenue came in at $103.86M versus an estimated $96.35M. He also outlines the acquisition of Vyrsa Technologies. Tune in to find out more about the stock market today.

Morning Trade Live

08 Dec 2023

SHARE

ON AIR
education
2:00 am
Your First Trade
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
ON AIR
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Opening Bell With Nicole Petallides
9:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
education
7:30 pm
Liz Ann Live
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market On Close
REPLAY
education
10:00 pm
Liz Ann Live
REPLAY
10:30 pm
The Wrap
REPLAY

Schwab Network's Newsletters

Daily insights for every investor